Results 111 to 120 of about 304,872 (183)

Comprehensive characterization of gastrointestinal microbiota dysbiosis in patients with refractory <i>Helicobacter pylori</i> infection. [PDF]

mSystems
Li Y, Xu X, Peng C, Liu Y, Lu N, Zhu Y, He C.   +6 more
europepmc   +1 more source

Helicobacter pylori infection is associated with an increased risk of chronic obstructive pulmonary disease and asthma. [PDF]

Gut Pathog
Chung C, Lee KN, Han K, Shin DW, Lee SW.
europepmc   +1 more source

An pH-responsive liposome for the targeted treatment of <i>Helicobacter pylori</i>. [PDF]

Mater Today Bio
Dong H, Guan A, Yang S, Wang L, Zhao L, Chen H, Wei H, Luo P, Huang Y.   +8 more
europepmc   +1 more source

[Clinical and microbiological effectiveness of Helicobacter pylori eradication treatment with triple therapy]. [PDF]

Aten Primaria
Ghandour Fawaz Y, Rojo Ruiz N, Díaz Núñez J, Sariola Molins A, Barreales Soto S, Vilaseca Canals J.   +5 more
europepmc   +1 more source

Correlation between <i>Helicobacter pylori</i> infection and severity of gastritis in children. [PDF]

Microbiol Spectr
Zheng W, Chen X, Yang Y, Peng K, Li F, Zhao H, Gu W, Jiang M.   +7 more
europepmc   +1 more source

<i>Helicobacter pylori</i>-induced miR-136 is a potential predictor of early-stage gastric cancer. [PDF]

World J Gastrointest Oncol
Chen T, Feng AQ, Shen XR, Dang NY, Ye F, Zhang GX.   +5 more
europepmc   +1 more source

Effects of a combination of bifidobacteria quadruple viable bacteria tablets and quadruple therapy on inflammatory response and <i>Helicobacter pylori</i> eradication rate in patients with <i>Helicobacter pylori</i> positive gastric ulcers. [PDF]

Front Med (Lausanne)
Jiang C, Shi J, Zhuang X, Zhou M, Zhong H.   +4 more
europepmc   +1 more source